310271
Using health information technology for patient registries in patient-centered medical homes
Objectives: To examine 1) the HIT application usage in patient registry and 2) patient registry capabilities in PCMH.
Methods: Data were collected from a statewide survey of physician practices in 2012 (n=443) throughout Michigan participating in the Blue-Cross/Blue-Shield of Michigan’s Physician Group Incentive Program. EHR adoption, patient registry software usage, and patient registry capabilities were assessed.
Results: Of 443 physician practices, the adoption of EHR systems was 51.7%; and usage of patient registry software was 43.3%. Only 2.4% of registries were fully electronic, comprehensive and integrated, with analytic capabilities. Of 18 possible capabilities in patient registry, disease registries included: diabetes registry (30.4%), asthma (11.3%), coronary artery disease (11.3%), congestive heart failure (13.0%), chronic kidney disease (3.4%), pediatric obesity (2.2%), and pediatric ADHD (1.7%).
Discussion: Despite its important role in the PCMH, overall usage of EHR and patient registry software is low. For more efficient and better care coordination, the EHR and electronic patient registries adoption should be encouraged. Further studies are needed in exploring the reasons for low adoption of EHR and patient registries, and designing more efficient, effective and user satisfaction advanced HIT tools to provide high quality of care.
Learning Areas:
Chronic disease management and preventionCommunication and informatics
Learning Objectives:
Identify health information technology usage in patient registry in patient-centered medical home.
Discuss the needs and approaches for promotion of health information technology adoption in patient registry in patient-centered medical home.
Keyword(s): Information Technology, Patient-Centered Care
Qualified on the content I am responsible for because: I research Health IT and PCMHs.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.